307 related articles for article (PubMed ID: 18668496)
1. Reactivity and antiproliferative activity of ferrocenyl-tamoxifen adducts with cyclodextrins against hormone-independent breast-cancer cell lines.
Buriez O; Heldt JM; Labbé E; Vessières A; Jaouen G; Amatore C
Chemistry; 2008; 14(27):8195-203. PubMed ID: 18668496
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines.
Top S; Vessières A; Leclercq G; Quivy J; Tang J; Vaissermann J; Huché M; Jaouen G
Chemistry; 2003 Nov; 9(21):5223-36. PubMed ID: 14613131
[TBL] [Abstract][Full Text] [Related]
3. Influence of cyclodextrins on the proliferation of HaCaT keratinocytes in vitro.
Hipler UC; Schönfelder U; Hipler C; Elsner P
J Biomed Mater Res A; 2007 Oct; 83(1):70-9. PubMed ID: 17380497
[TBL] [Abstract][Full Text] [Related]
4. Biological activity of water-soluble inclusion complexes of 1'-acetoxychavicol acetate with cyclodextrins.
Azuma H; Aizawa Y; Higashitani N; Tsumori T; Kojima-Yuasa A; Matsui-Yuasa I; Nagasaki T
Bioorg Med Chem; 2011 Jun; 19(12):3855-63. PubMed ID: 21596572
[TBL] [Abstract][Full Text] [Related]
5. Aggregation of cyclodextrins as an important factor to determine their complexation behavior.
Bikádi Z; Kurdi R; Balogh S; Szemán J; Hazai E
Chem Biodivers; 2006 Nov; 3(11):1266-78. PubMed ID: 17193241
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationships of ferrocenyl tamoxifen derivatives with modified side chains.
Nguyen A; Top S; Pigeon P; Vessières A; Hillard EA; Plamont MA; Huché M; Rigamonti C; Jaouen G
Chemistry; 2009; 15(3):684-96. PubMed ID: 19053086
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationships of the first ferrocenyl-aryl-hydantoin derivatives of the nonsteroidal antiandrogen nilutamide.
Payen O; Top S; Vessières A; Brulé E; Plamont MA; McGlinchey MJ; Müller-Bunz H; Jaouen G
J Med Chem; 2008 Mar; 51(6):1791-9. PubMed ID: 18303829
[TBL] [Abstract][Full Text] [Related]
8. Role of aromatic substituents on the antiproliferative effects of diphenyl ferrocenyl butene compounds.
Zekri O; Hillard EA; Top S; Vessières A; Pigeon P; Plamont MA; Huché M; Boutamine S; McGlinchey MJ; Müller-Bunz H; Jaouen G
Dalton Trans; 2009 Jun; (22):4318-26. PubMed ID: 19662309
[TBL] [Abstract][Full Text] [Related]
9. Ferrocene-mediated proton-coupled electron transfer in a series of ferrocifen-type breast-cancer drug candidates.
Hillard E; Vessières A; Thouin L; Jaouen G; Amatore C
Angew Chem Int Ed Engl; 2005 Dec; 45(2):285-90. PubMed ID: 16312004
[No Abstract] [Full Text] [Related]
10. Cytotoxicity of a series of ferrocene-containing beta-diketones.
Swarts JC; Vosloo TG; Cronje SJ; Du Plessis WC; Van Rensburg CE; Kreft E; Van Lier JE
Anticancer Res; 2008; 28(5A):2781-4. PubMed ID: 19035310
[TBL] [Abstract][Full Text] [Related]
11. Phthalimido-ferrocidiphenol cyclodextrin complexes: Characterization and anticancer activity.
Najlaoui F; Pigeon P; Abdelkafi Z; Leclerc S; Durand P; Ayeb ME; Marrakchi N; Rhouma A; Jaouen G; Gibaud S
Int J Pharm; 2015 Aug; 491(1-2):323-34. PubMed ID: 26136201
[TBL] [Abstract][Full Text] [Related]
12. The influence of phenolic hydroxy substitution on the electron transfer and anti-cancer properties of compounds based on the 2-ferrocenyl-1-phenyl-but-1-ene motif.
Hillard EA; Pigeon P; Vessières A; Amatore C; Jaouen G
Dalton Trans; 2007 Nov; (43):5073-81. PubMed ID: 17992292
[TBL] [Abstract][Full Text] [Related]
13. A [3]ferrocenophane polyphenol showing a remarkable antiproliferative activity on breast and prostate cancer cell lines.
Plazuk D; Vessières A; Hillard EA; Buriez O; Labbé E; Pigeon P; Plamont MA; Amatore C; Zakrzewski J; Jaouen G
J Med Chem; 2009 Aug; 52(15):4964-7. PubMed ID: 19526991
[TBL] [Abstract][Full Text] [Related]
14. [Cytotoxic examinations of various cyclodextrin derivatives on Caco-2 cells].
Kiss T; Fenyvesi F; Kovácsné BI; Fehér P; Leposáné KR; Váradi J; Szente L; Fenyvesi E; Iványi R; Vecsernyés M
Acta Pharm Hung; 2007; 77(2):150-4. PubMed ID: 17933275
[TBL] [Abstract][Full Text] [Related]
15. Organometallic cyclic polyphenols derived from 1,2-(alpha-keto tri or tetra methylene) ferrocene show strong antiproliferative activity on hormone-independent breast cancer cells.
Plazuk D; Top S; Vessières A; Plamont MA; Huché M; Zakrzewski J; Makal A; Woźniak K; Jaouen G
Dalton Trans; 2010 Aug; 39(32):7444-50. PubMed ID: 20614088
[TBL] [Abstract][Full Text] [Related]
16. Ferrocene-containing carbohydrate dendrimers.
Ashton PR; Balzani V; Clemente-León M; Colonna B; Credi A; Jayaraman N; Raymo FM; Stoddart JF; Venturi M
Chemistry; 2002 Feb; 8(3):673-84. PubMed ID: 11855715
[TBL] [Abstract][Full Text] [Related]
17. Modification of the estrogenic properties of diphenols by the incorporation of ferrocene. Generation of antiproliferative effects in vitro.
Vessières A; Top S; Pigeon P; Hillard E; Boubeker L; Spera D; Jaouen G
J Med Chem; 2005 Jun; 48(12):3937-40. PubMed ID: 15943467
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, structure, and in vitro antitumor activity of some glycoside derivatives of ferrocenyl-chalcones and ferrocenyl-pyrazolines.
Zsoldos-Mády V; Csámpai A; Szabó R; Mészáros-Alapi E; Pásztor J; Hudecz F; Sohár P
ChemMedChem; 2006 Oct; 1(10):1119-25. PubMed ID: 16944543
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, cytotoxicity, and COMPARE analysis of ferrocene and [3]ferrocenophane tetrasubstituted olefin derivatives against human cancer cells.
Görmen M; Pigeon P; Top S; Hillard EA; Huché M; Hartinger CG; de Montigny F; Plamont MA; Vessières A; Jaouen G
ChemMedChem; 2010 Dec; 5(12):2039-50. PubMed ID: 20949584
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antiproliferative activity of hydroxyferrocifen hybrids against triple-negative breast cancer cells.
Cázares-Marinero Jde J; Top S; Vessières A; Jaouen G
Dalton Trans; 2014 Jan; 43(2):817-30. PubMed ID: 24153445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
